Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Gains from Investment Securities (2022 - 2023)

Historic Gains from Investment Securities for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $105000.0.

  • Lexeo Therapeutics' Gains from Investment Securities fell 277.78% to $105000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $425000.0, marking a year-over-year change of. This contributed to the annual value of $410000.0 for FY2024, which is 352.94% down from last year.
  • Latest data reveals that Lexeo Therapeutics reported Gains from Investment Securities of $105000.0 as of Q4 2023, which was down 277.78% from $107000.0 recorded in Q3 2023.
  • Over the past 5 years, Lexeo Therapeutics' Gains from Investment Securities peaked at $110000.0 during Q1 2023, and registered a low of $36000.0 during Q3 2022.